MPP Logo
Twitter LinkedIn YouTube
Search
English / Français
Ethics Portal
Twitter LinkedIn YouTube
Search
English / Français
Ethics Portal
  • Who We Are
    • About Us
    • Governance & Team
    • Business Model
    • Statutes, By-Laws & Policies
    • Annual Reports
    • Careers & RFPs
  • What We Do
    • Licensing for Public Health
    • Strategy
    • Prioritising Medicines for Licensing
    • Disease Areas
      • HIV
      • Viral Hepatitis
      • TB
      • COVID-19
      • New Disease Areas
    • Addressing Children’s Needs
    • MedsPaL
    • Long-Acting Therapeutics
  • Progress
    • Impact
    • Licences
    • Access to Medicines Tracker
    • Contribution to Universal Health Coverage
    • Endorsements
  • Our Stories
    • Kenya
    • Ukraine
    • India
    • Voices from Friends of MPP
  • News & Publications
    • News, Events & Press Releases
    • Messages from the Executive Director
    • MPP in the Media
    • MPP Publications
    • Related Publications
    • Newsletters & Updates
  • Partners
    • COVID-19 Open Pledge
    • Partnering with MPP
    • Funders
    • How to give or get a licence
  • Contact Us
Cookie Policy

Cookie Policy

Some of our web pages utilise “cookies”. A “cookie” is a small file that may be used, for example, to collect information about web site activity. Some cookies and other technologies may serve to recall personal information previously indicated by a web user. Most browsers allow you to control cookies, including providing you with options to accept or remove them.

Some cookies are necessary for the operation of this website. If you choose to block them, some aspects of the site may not work for you. Other cookies, such as those set in Google Analytics, our statistics package, are only activated with your explicit consent.

Protecting your privacy online is an evolving area and this website will constantly attempt to improve its functions to meet user demands.

Share

Contact Us

Press and Media

About Us

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.

Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with ten patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC).

MPP Logo

Subscribe to our Newsletter

Subscribe to our Newsletter

Subscribe

* indicates required






The Medicines Patent Pool will use the information (email address) you provide on this form to be in touch with you and to provide updates.


You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at press@medicinespatentpool.org. We will treat your information with respect. For more information about our privacy practices, please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.


About Us
Licences
MedsPaL
Careers & RFPs
Contact

Founded & funded by

Unitaid Logo

Other funders

Cookie Policy
This website uses cookies to ensure you get the best experience on our website. Learn More
Decline Allow Cookies